Advertisement

U.S. markets open in 5 hours 32 minutes

S&P Futures
3,778.00
-43.25(-1.13%)
Dow Futures
30,703.00
-296.00(-0.95%)
Nasdaq Futures
11,536.75
-154.25(-1.32%)
Russell 2000 Futures
1,701.40
-20.00(-1.16%)
Crude Oil
109.36
-0.42(-0.38%)
Gold
1,813.90
-3.60(-0.20%)

Advertisement

Pyxis Oncology, Inc. (PYXS)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W

2.3500

+0.0600

(+2.62%)

At close: 04:00PM EDT

2.3500

0.00

(0.00%)

After hours:

04:08PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bearishpattern detected

Short-term KST

View all chart patterns

Performance Outlook

Previous Close	2.2900
Open	2.3500
Bid	0.0000 x 3200
Ask	0.0000 x 3100
Day's Range	2.2250 - 2.3900
52 Week Range	1.9600 - 19.0000
Volume	73,827
Avg. Volume	247,738

Market Cap	77.12M
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	-4.3440
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	15.75

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for PYXS

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Pyxis Oncology, Inc.
Daily – Vickers Top Buyers & Sellers for 01/18/2022The Vickers Top Buyers & Sellers is a daily report that identifies the five companies the largest insider purchase transactions based on the dollar value of the transactions as well as the five companies the largest insider sales transactions based on the dollar value of the transactions.
Rating
Fair Value
Economic Moat
5 months agoArgus Research

All

GlobeNewswire
Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference
CAMBRIDGE, Mass., June 28, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), an oncology company focused on developing next-generation therapeutics for difficult-to-treat cancers, today announced that the Company will present at the H.C. Wainwright Preclinical Cancer Drug Discovery - Antibody Drug Conjugates (ADCs) virtual conference. The pre-recorded presentation given by Lara Sullivan, M.D., President and Chief Executive Officer, and Jay Feingold, M.D., Ph.D., Chief Medical Officer
- Two Yepez HRs, Goldschmidt 4 for 4, Cards top Marlins 9-0
  NBC Sports
- Araris Biotech AG to Present at the H.C. Wainwright Preclinical Cancer Drug Discovery Virtual Conference
  GlobeNewswire
Simply Wall St.
Great news for Pyxis Oncology, Inc. (NASDAQ:PYXS): Insiders acquired stock in large numbers last year
Generally, when a single insider buys stock, it is usually not a big deal. However, when several insiders are buying...
GlobeNewswire
Pyxis Oncology Announces Presentations at Upcoming Investor Conferences
CAMBRIDGE, Mass., May 19, 2022 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, and members of the management team will present at the following upcoming investor conferences: H.C. Wainwright Global Investment ConferenceDate: Tuesday, May 24, 2022Time: 7:00 a.m. ETFormat: Pre-recorded prese